MetLife/$MET

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About MetLife

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.

Ticker

$MET
Sector

Primary listing

NYSE

Employees

45,000

MetLife Metrics

BasicAdvanced
$54B
13.66
$5.92
0.86
$2.23
2.81%

What the Analysts think about MetLife

Analyst ratings (Buy, Hold, Sell) for MetLife stock.

Bulls say / Bears say

MetLife’s first-quarter profit rose 5% year-over-year to $1.96 per share, driven by higher premiums and investment income, and the insurer launched a $3 billion share buyback program, reflecting management’s confidence in the business (Reuters).
AM Best affirmed MetLife’s Financial Strength Rating of A+ (Superior) and its long-term issuer credit ratings of aa- (Superior), highlighting the company’s robust balance sheet strength, financial flexibility and strong operating performance (AM Best).
In the second quarter of 2025, MetLife’s net investment income increased 9% to $5.7 billion, demonstrating resilience in its diversified, bond-heavy investment portfolio amid market volatility (Reuters).
MetLife’s second-quarter adjusted profit declined 16% year-over-year to $1.36 billion, primarily due to weaker premiums and less favorable underwriting margins in its life and non-medical health insurance segments (Reuters).
In the same quarter, adjusted premiums, fees and other revenues fell 6% to $12.72 billion, underscoring operational headwinds in MetLife’s core insurance businesses (Reuters).
Despite solid fundamentals, MetLife’s share price has slid nearly 8% year-to-date through Q1 2025, underperforming the S&P 500 and signaling investor skepticism about future growth prospects (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2025.

MetLife Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MetLife Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MET

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs